Freeline Therapeutics Holdings plc Total Current Liabilities

Freeline Therapeutics Holdings plc (FRLN) currently reports a total current liabilities of $17M as of September 2023. That compares with $22M in the prior-year period — down 22.0% year over year. Use the charts on this page to explore Freeline Therapeutics Holdings plc's total current liabilities history and peer comparisons.

Freeline Therapeutics Holdings plc's total current liabilities decreased from $22M to $17M — a 22.0% year-over-year decrease (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Freeline Therapeutics Holdings plc reported $17M in total current liabilities as of September 2023. That compares with $22M in the prior-year period — down 22.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total current liabilities of $17M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Freeline Therapeutics Holdings plc, and consider following FRLN for alerts when major investors trade the stock.

Freeline Therapeutics Holdings plc is classified in the Healthcare sector. On total current liabilities, it currently shows $17M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing FRLN with unrelated industries.